Key Points: In today’s Recommendation for Industry, we discuss the ongoing monkeypox headlines. Read more below. US COVID cases show hints of decline. The 7-day
Key Points: In today’s Recommendation for Industry, we discuss CDC’s reduction in COVID guidelines. Read more below. New York Times reports updates about COVID: Hospitalizations
Key Points: In today’s Recommendation for Industry, we discuss if there is a risk of monkeypox transmission within the workplace. Read more below. Moderna announces
Key Points: In today’s Recommendation for Industry, we discuss COVID becoming an endemic virus. Read more below. COVID hot spots shift; studies add evidence for
Key Points: In today’s Recommendation for Industry, we discuss the continuing evolution of COVID vaccines. Read more below. Feds look ahead to next-generation COVID vaccines.
Key Points: In today’s Recommendation for Industry, we discuss how COVID cases are rising. Read more below. CDC panel recommends Novavax vaccine as BA.5 gains
Key Points: In today’s Recommendation for Industry, we discuss BA.5’s continued transmission and low severity. Read more below. FDA green-lights Novavax vaccine as COVID-19 levels
Key Points: In today’s Recommendation for Industry, we discuss the continued westward wave of COVID. Read more below. Coronavirus (COVID-19) Update: FDA Authorizes Emergency Use
Key Points: In today’s Recommendation for Industry, we discuss the possibility of COVID transmission from packaging. Read more below. Nitric oxide boosts oxygen in pregnant
